Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis. (2019)

First Author: Simmons B

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(19)30266-9

PubMed Identifier: 31362914

Publication URI: http://europepmc.org/abstract/MED/31362914

Type: Journal Article/Review

Volume: 7

Parent Publication: The Lancet. Global health

Issue: 9

ISSN: 2214-109X